TR200001423T2 - Erimiş paroksetin içeren yeni formülasyonlar - Google Patents
Erimiş paroksetin içeren yeni formülasyonlarInfo
- Publication number
- TR200001423T2 TR200001423T2 TR2000/01423T TR200001423T TR200001423T2 TR 200001423 T2 TR200001423 T2 TR 200001423T2 TR 2000/01423 T TR2000/01423 T TR 2000/01423T TR 200001423 T TR200001423 T TR 200001423T TR 200001423 T2 TR200001423 T2 TR 200001423T2
- Authority
- TR
- Turkey
- Prior art keywords
- paroxetine
- formulations containing
- containing molten
- solid
- new formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Paroksetinin kati, yari kati ya da sivi bir tasiyici içinde bulundugu Paroksetinin farmasötik formülasyonlari sunulmustur. Çözeltiler kapsülleri doldurmak için kullanildigi gibi kati çözeltiler de tablet ya da pelletler gibi kendi basina kullanilabilecek sekillere getirildi. Kapsamda ayrica, paroksetini yaglar ve/veya lipidler içinde çözmek için bir çözücü maddenin kullanildigi yeni sivi formülasyonlar ve anhidre ya da hidrofobik tasiyicilar ya da yardimci maddelerin kullanimi ile hemihidrata dönüsen baska paroksetin formlarindan kaçinmak için metodlar da bulunmaktadir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9724544.3A GB9724544D0 (en) | 1997-11-21 | 1997-11-21 | Novel Formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200001423T2 true TR200001423T2 (tr) | 2000-10-23 |
Family
ID=10822374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/01423T TR200001423T2 (tr) | 1997-11-21 | 1998-11-18 | Erimiş paroksetin içeren yeni formülasyonlar |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1033986A1 (tr) |
JP (1) | JP2001523718A (tr) |
KR (1) | KR20010032320A (tr) |
CN (1) | CN1279608A (tr) |
AP (1) | AP2000001821A0 (tr) |
AR (1) | AR015485A1 (tr) |
AU (1) | AU1168099A (tr) |
BG (1) | BG104527A (tr) |
BR (1) | BR9814220A (tr) |
CO (1) | CO4970832A1 (tr) |
DZ (1) | DZ2658A1 (tr) |
EA (1) | EA200000552A1 (tr) |
GB (1) | GB9724544D0 (tr) |
HU (1) | HUP0100580A3 (tr) |
IL (1) | IL136106A0 (tr) |
MA (1) | MA24704A1 (tr) |
NO (1) | NO20002590L (tr) |
OA (1) | OA11385A (tr) |
PE (1) | PE20000381A1 (tr) |
PL (1) | PL340555A1 (tr) |
SK (1) | SK7342000A3 (tr) |
TR (1) | TR200001423T2 (tr) |
WO (1) | WO1999026625A1 (tr) |
ZA (1) | ZA9810637B (tr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9810180D0 (en) * | 1998-05-13 | 1998-07-08 | Smithkline Beecham Plc | Novel formulation |
CA2367402C (en) * | 1999-03-12 | 2010-11-23 | Basf Aktiengesellschaft | Stable pharmaceutical dosage form for paroxetine anhydrate |
WO2001002393A1 (en) | 1999-07-01 | 2001-01-11 | Italfarmaco S.P.A. | Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives |
DE19930454A1 (de) * | 1999-07-02 | 2001-01-04 | Knoll Ag | Feste Paroxetin enthaltende Zubereitungen |
US6720003B2 (en) | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
ES2294197T3 (es) * | 2001-12-21 | 2008-04-01 | Supernus Pharmaceuticals, Inc. | Formulacion de capsula oral con estabilidad fisica aumentada. |
SE0200475D0 (sv) * | 2002-02-15 | 2002-02-15 | Ltp Lipid Technologies Provide | Oral farmaceutisk beredning |
WO2006119779A2 (en) * | 2005-05-10 | 2006-11-16 | Lifecycle Pharma A/S | A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution |
US20120322752A1 (en) * | 2009-12-08 | 2012-12-20 | Sung Kyun Lee | SOLID DISPERSIONS CONTAINING 20-O-beta-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL |
GB201020032D0 (en) * | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
CN103961333B (zh) * | 2014-05-07 | 2020-02-21 | 浙江华海药业股份有限公司 | 甲磺酸帕罗西汀胶囊及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996031197A1 (en) * | 1995-04-03 | 1996-10-10 | Abbott Laboratories | Homogeneous mixtures of low temperature-melting drugs and additives for controlled release |
HUP0000960A3 (en) * | 1997-01-15 | 2001-04-28 | Smithkline Beecham Plc | Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same |
-
1997
- 1997-11-21 GB GBGB9724544.3A patent/GB9724544D0/en not_active Ceased
-
1998
- 1998-11-18 CN CN98811404A patent/CN1279608A/zh active Pending
- 1998-11-18 WO PCT/GB1998/003471 patent/WO1999026625A1/en not_active Application Discontinuation
- 1998-11-18 PE PE1998001126A patent/PE20000381A1/es not_active Application Discontinuation
- 1998-11-18 EP EP98954631A patent/EP1033986A1/en not_active Withdrawn
- 1998-11-18 PL PL98340555A patent/PL340555A1/xx unknown
- 1998-11-18 TR TR2000/01423T patent/TR200001423T2/tr unknown
- 1998-11-18 AP APAP/P/2000/001821A patent/AP2000001821A0/en unknown
- 1998-11-18 KR KR1020007005532A patent/KR20010032320A/ko not_active Application Discontinuation
- 1998-11-18 SK SK734-2000A patent/SK7342000A3/sk unknown
- 1998-11-18 BR BR9814220-8A patent/BR9814220A/pt not_active Application Discontinuation
- 1998-11-18 JP JP2000521827A patent/JP2001523718A/ja active Pending
- 1998-11-18 DZ DZ980268A patent/DZ2658A1/xx active
- 1998-11-18 IL IL13610698A patent/IL136106A0/xx unknown
- 1998-11-18 HU HU0100580A patent/HUP0100580A3/hu unknown
- 1998-11-18 AU AU11680/99A patent/AU1168099A/en not_active Abandoned
- 1998-11-18 EA EA200000552A patent/EA200000552A1/ru unknown
- 1998-11-19 MA MA25357A patent/MA24704A1/fr unknown
- 1998-11-19 AR ARP980105880A patent/AR015485A1/es unknown
- 1998-11-20 ZA ZA9810637A patent/ZA9810637B/xx unknown
- 1998-11-20 CO CO98068459A patent/CO4970832A1/es unknown
-
2000
- 2000-05-19 NO NO20002590A patent/NO20002590L/no not_active Application Discontinuation
- 2000-05-19 OA OA1200000153A patent/OA11385A/en unknown
- 2000-06-13 BG BG104527A patent/BG104527A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BG104527A (en) | 2001-04-30 |
AU1168099A (en) | 1999-06-15 |
OA11385A (en) | 2004-01-27 |
MA24704A1 (fr) | 1999-07-01 |
ZA9810637B (en) | 2000-05-22 |
DZ2658A1 (fr) | 2003-03-22 |
BR9814220A (pt) | 2001-12-26 |
EP1033986A1 (en) | 2000-09-13 |
HUP0100580A2 (hu) | 2002-04-29 |
NO20002590D0 (no) | 2000-05-19 |
PL340555A1 (en) | 2001-02-12 |
PE20000381A1 (es) | 2000-05-07 |
NO20002590L (no) | 2000-07-19 |
EA200000552A1 (ru) | 2000-10-30 |
JP2001523718A (ja) | 2001-11-27 |
SK7342000A3 (en) | 2000-12-11 |
CN1279608A (zh) | 2001-01-10 |
CO4970832A1 (es) | 2000-11-07 |
IL136106A0 (en) | 2001-05-20 |
WO1999026625A1 (en) | 1999-06-03 |
HUP0100580A3 (en) | 2002-05-28 |
GB9724544D0 (en) | 1998-01-21 |
AR015485A1 (es) | 2001-05-02 |
KR20010032320A (ko) | 2001-04-16 |
AP2000001821A0 (en) | 2000-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200001423T2 (tr) | Erimiş paroksetin içeren yeni formülasyonlar | |
ATE429210T1 (de) | Orale flüssige zusammensetzungen | |
FR2361914A1 (fr) | Nouvelles formulations de medicaments a danger d'emploi abusif reduit | |
KR880701544A (ko) | 이온화 가능한 의약 제제용 용해 시스템 | |
KR880004804A (ko) | 분무건조 아세트 아미노펜 | |
GB1204580A (en) | Pharmaceutical dosage forms | |
JPS542316A (en) | Solid pharmaceutical composition containing nifedipene | |
KR880009018A (ko) | 3-l-피로글루타밀-l-티아졸리딘-4-카르복실산 및 이의 제법 | |
TR200503846T2 (tr) | Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı | |
JPS5420126A (en) | Pharmaceutical composition | |
DE3773017D1 (de) | Nicorandil enthaltende zubereitung zum einspritzen. | |
JPS52128210A (en) | Preparation of soft capsule for 1alpha-hydroxyvitamind derivatives | |
WO1998005308A3 (en) | Terazosin capsules | |
JPS5363938A (en) | Dynamic memory unit | |
TR200101083T2 (tr) | (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim. | |
EA199900510A1 (ru) | Инъекционное лекарственное средство "цитофлавин", обладающее цитопротекторным действием | |
JPS5361918A (en) | Display device | |
KR970073593A (ko) | 진세노사이드 Rg_5를 함유하는 항암제 조성물 | |
JPS5251362A (en) | Preparation of optically active pyrrolidine derivatives | |
DE69416034D1 (de) | Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen | |
IT1226923B (it) | Dispositivo per allineare capsule. | |
JPS5283413A (en) | Preparation of 3,3-dimethyl-4-pentenoic acid or its esters | |
JPS5283411A (en) | Preparation of 3,3-dimethyl-4-pentenoic acid and its derivatives | |
ES334301A1 (es) | Procedimiento para la preparacion de 1,3-dihidro-2-oxo-5- fenil-2h-1,4-benzodiacepinas. | |
ES2004693A6 (es) | Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo. |